Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial-Reference-Cited by-同舟云学术

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Published:2023-08 Issue:8 Volume:10 Page:e612-e623
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Ragni Margaret V^ORCID,Rothenberger Scott D^ORCID,Feldman Robert,Nance Danielle^ORCID,Leavitt Andrew D,Malec Lynn,Kulkarni Roshni^ORCID,Sidonio Robert^ORCID,Kraut Eric,Lasky Joseph^ORCID,Pruthi Rajiv^ORCID,Angelini Dana,Philipp Claire^ORCID,Hwang Nina^ORCID,Wheeler Allison P^ORCID,Seaman Craig^ORCID,Machin Nicoletta,Xavier Frederico^ORCID,Meyer Michael,Bellissimo Daniel,Humphreys Gregory,Smith Kenneth J^ORCID,Merricks Elizabeth P,Nichols Timothy C^ORCID,Ivanco Dana,Vehec Deborah,Koerbel Glory,Althouse Andrew D^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Epidemiological investigation of the prevalence of von Willebrand's disease;Rodeghiero;Blood,1987

2. von Willebrand's disease;Leebeek;N Engl J Med,2016

3. von Willebrand disease and bleeding in women;Ragni;Haemophilia,1999

4. Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease;Govorov;Exp Ther Med,2016

5. The impact of menstrual disorders on quality of life in women with inherited bleeding disorders;Kadir;Haemophilia,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. von Willebrand disease;Nature Reviews Disease Primers;2024-07-25

2. Women and girls with inherited bleeding disorders: Focus on haemophilia carriers and heavy menstrual bleeding;Haemophilia;2024-03-26

3. Tranexamic Acid: An Evergreen Hemostatic Agent;Seminars in Thrombosis and Hemostasis;2024-02-09

4. Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies;Seminars in Thrombosis and Hemostasis;2024-02-08

5. New and emerging therapies for women, girls, and people with the potential to menstruate with VWD;Blood Advances;2023-12-14